• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI

NEUROTECH INTERNATIONAL LIMITED - Announcements

7.69% ! 1.4¢
Market Cap $14.69M  !

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Announcements



NTI Becoming a substantial holder02/10/20 download Created with Sketch. 39.17KB
NTI Completion of Acquisition30/09/20 download Created with Sketch. 70.15KB
NTI NTI Commences Landmark In Vitro Trials of Cannabis Strains23/09/20 download Created with Sketch. 78.36KB
NTI Ceasing to be a substantial holder10/09/20 download Created with Sketch. 12.09KB
NTI Completion of Placement07/09/20 download Created with Sketch. 63.07KB
NTI Neurotech Proceeds to in vitro trials after Positive ResultsPRICE SENSITIVE07/09/20 download Created with Sketch. 472.55KB
NTI Neurotech secures Brain Therapeutics as Greece distributor03/09/20 download Created with Sketch. 84.52KB
NTI Appendix 2A02/09/20 download Created with Sketch. 217.56KB
NTI Appendix 4E and Annual Report Updated31/08/20 download Created with Sketch. 731.36KB
NTI Appendix 4G31/08/20 download Created with Sketch. 387.97KB
NTI Appendix 4E and Annual ReportPRICE SENSITIVE31/08/20 download Created with Sketch. 718.09KB
NTI Results of Meeting31/08/20 download Created with Sketch. 90.89KB
NTI Disclosure DocumentPRICE SENSITIVE26/08/20 download Created with Sketch. 422.17KB
NTI Response to ASX price queryPRICE SENSITIVE21/08/20 download Created with Sketch. 657.35KB
NTI Pause in TradingPRICE SENSITIVE21/08/20 download Created with Sketch. 113.83KB
NTI Promising Early Results from Cannabinoid AnalysisPRICE SENSITIVE21/08/20 download Created with Sketch. 136.93KB
NTI Trading HaltPRICE SENSITIVE19/08/20 download Created with Sketch. 156.17KB
NTI Ceasing to be a substantial holder04/08/20 download Created with Sketch. 415.7KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE30/07/20 download Created with Sketch. 453.14KB
NTI Notice of General Meeting/Proxy Form28/07/20 download Created with Sketch. 1.18MB
NTI Neurotech commences assays on Dolce cannabis strains27/07/20 download Created with Sketch. 191.21KB
NTI Appendix 2A22/07/20 download Created with Sketch. 214.78KB
NTI Disclosure DocumentPRICE SENSITIVE15/07/20 download Created with Sketch. 374.05KB
NTI Change in substantial holding15/07/20 download Created with Sketch. 124.48KB
NTI Proposed issue of Securities - NTI03/07/20 download Created with Sketch. 24.71KB
NTI Proposed issue of Securities - NTI03/07/20 download Created with Sketch. 38.63KB
NTI NTI Secures Option to Cannabis Strains Targeting AutismPRICE SENSITIVE03/07/20 download Created with Sketch. 143.12KB
NTI Trading HaltPRICE SENSITIVE01/07/20 download Created with Sketch. 328.64KB
NTI Reinstatement to Official QuotationPRICE SENSITIVE01/05/20 download Created with Sketch. 71.3KB
NTI Response to ASX Price and Volume QueryPRICE SENSITIVE01/05/20 download Created with Sketch. 241.53KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE29/04/20 download Created with Sketch. 280.75KB
NTI Continued Suspension28/04/20 download Created with Sketch. 111.41KB
NTI Continued Suspension20/04/20 download Created with Sketch. 89.77KB
NTI Suspension from Official QuotationPRICE SENSITIVE14/04/20 download Created with Sketch. 183.29KB
NTI Becoming a substantial holder x409/04/20 download Created with Sketch. 5.7MB
NTI Mente receives CE Mark renewal for use with ASD ChildrenPRICE SENSITIVE09/04/20 download Created with Sketch. 170.22KB
NTI Trading HaltPRICE SENSITIVE08/04/20 download Created with Sketch. 213.23KB
NTI Pause In TradePRICE SENSITIVE08/04/20 download Created with Sketch. 115.74KB
NTI Appendix 3G06/04/20 download Created with Sketch. 279.99KB
NTI Secondary Trading Notice & Appendix 2A06/04/20 download Created with Sketch. 416.02KB
NTI Mente Continues to Build Awareness in Europe26/03/20 download Created with Sketch. 128.67KB
NTI Appendix 3G04/03/20 download Created with Sketch. 280.3KB
NTI Secondary Trading Notice & Appendix 2A04/03/20 download Created with Sketch. 368.73KB
NTI Appendix 4D & Half Year ReportPRICE SENSITIVE25/02/20 download Created with Sketch. 394.5KB
NTI New Mente Autism Therapy Referral Program24/02/20 download Created with Sketch. 133.83KB
NTI Response to Appendix 4C QueryPRICE SENSITIVE17/02/20 download Created with Sketch. 268.3KB
NTI Ceasing to be a substantial holder04/02/20 download Created with Sketch. 516.11KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE03/02/20 download Created with Sketch. 327.11KB
NTI Cancellation of Mente Device from Australian TGA RegisterPRICE SENSITIVE28/01/20 download Created with Sketch. 97.39KB
NTI Trading HaltPRICE SENSITIVE24/01/20 download Created with Sketch. 155.47KB
NTI Change of Share Registry20/01/20 download Created with Sketch. 234.34KB
NTI Neurotech Expands Distribution to Taiwan17/12/19 download Created with Sketch. 70.45KB
NTI Mente Partnership with Australian Neurofeedback Institute05/12/19 download Created with Sketch. 165.8KB
NTI Change of Director's Interest Notice x 419/11/19 download Created with Sketch. 838.99KB
NTI Appendix 3B - AGM Securities Issues19/11/19 download Created with Sketch. 472.44KB
NTI Amended Constitution19/11/19 download Created with Sketch. 456.71KB
NTI Results of Meeting19/11/19 download Created with Sketch. 525.91KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE31/10/19 download Created with Sketch. 198.79KB
NTI Notice of Annual General Meeting/Proxy Form16/10/19 download Created with Sketch. 758.25KB
NTI Capital Raising08/10/19 download Created with Sketch. 77.05KB
NTI Appendix 4G30/08/19 download Created with Sketch. 234.82KB
NTI Appendix 4E and Annual Report to ShareholdersPRICE SENSITIVE30/08/19 download Created with Sketch. 715.77KB
NTI Quarterly Update & Appendix 4CPRICE SENSITIVE31/07/19 download Created with Sketch. 279.41KB
NTI Response to ASX Price and Volume QueryPRICE SENSITIVE18/07/19 download Created with Sketch. 252.46KB
NTI Response to ASX Price and Volume QueryPRICE SENSITIVE05/06/19 download Created with Sketch. 669.72KB
NTI Neurotech launches Mente Clinic05/06/19 download Created with Sketch. 85.8KB
NTI Change in substantial holding03/06/19 download Created with Sketch. 75.94KB
NTI Change in substantial holding03/06/19 download Created with Sketch. 63.88KB
NTI Response to ASX Price and Volume QueryPRICE SENSITIVE29/05/19 download Created with Sketch. 192.56KB
NTI Pause In TradingPRICE SENSITIVE29/05/19 download Created with Sketch. 116.2KB
NTI Quarterly Activities and Cashflow ReportPRICE SENSITIVE30/04/19 download Created with Sketch. 323.18KB
NTI Response to ASX Price QueryPRICE SENSITIVE24/04/19 download Created with Sketch. 414.61KB
NTI Details of Company Address23/04/19 download Created with Sketch. 55.87KB
NTI Initial Director's Interest Notice18/04/19 download Created with Sketch. 150.95KB
NTI Initial Director's Interest Notice18/04/19 download Created with Sketch. 150.42KB
NTI Appendix 3Z - P O'Connor17/04/19 download Created with Sketch. 177.1KB
NTI Appendix 3Z - N Fong17/04/19 download Created with Sketch. 176.71KB
NTI Appendix 3Z - S Trevisan17/04/19 download Created with Sketch. 179.3KB
NTI New Board Appointments16/04/19 download Created with Sketch. 174.6KB
NTI Ceasing to be a substantial holder08/04/19 download Created with Sketch. 148.91KB
NTI Dr Adrian Attard Trevisan, clarification28/03/19 download Created with Sketch. 117.51KB
NTI Dr Adrian Attard TrevisanPRICE SENSITIVE27/03/19 download Created with Sketch. 122.01KB
NTI New Subscription Model and E-Commerce platform for clinics18/03/19 download Created with Sketch. 155.73KB
NTI Maltese Former Employee Claim07/03/19 download Created with Sketch. 152.36KB
NTI Appendix 3Y - P O'Connor01/03/19 download Created with Sketch. 212.8KB
NTI Appendix 3Y - P Griffiths01/03/19 download Created with Sketch. 232.28KB
NTI Appendix 3Y - S Trevisan01/03/19 download Created with Sketch. 214.1KB
NTI Appendix 4D and 31 December 2018 Half Year ReportPRICE SENSITIVE28/02/19 download Created with Sketch. 1.01MB
NTI Becoming a substantial holder28/02/19 download Created with Sketch. 621.41KB
NTI Change in substantial holding27/02/19 download Created with Sketch. 188.88KB
NTI Appendix 3B25/02/19 download Created with Sketch. 469.88KB
NTI RENOUNCEABLE PRO-RATA RIGHTS ISSUEPRICE SENSITIVE25/02/19 download Created with Sketch. 126.97KB
NTI Neurotech secures digital marketing partner15/02/19 download Created with Sketch. 158.54KB
NTI Supplementary ProspectusPRICE SENSITIVE07/02/19 download Created with Sketch. 126.71KB
NTI Despatch of Prospectus06/02/19 download Created with Sketch. 171.94KB
NTI Despatch of Notices to Shareholders31/01/19 download Created with Sketch. 385.33KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE31/01/19 download Created with Sketch. 498.23KB
NTI Despatch of Notice to Optionholders30/01/19 download Created with Sketch. 323.77KB
NTI Appendix 3B30/01/19 download Created with Sketch. 521.71KB
NTI CEO and Managing Director remuneration29/01/19 download Created with Sketch. 161.77KB
NTI Becoming a substantial holder
02/10/20 download Created with Sketch. 39.17KB
NTI Completion of Acquisition
30/09/20 download Created with Sketch. 70.15KB
NTI NTI Commences Landmark In Vitro Trials of Cannabis Strains
23/09/20 download Created with Sketch. 78.36KB
NTI Ceasing to be a substantial holder
10/09/20 download Created with Sketch. 12.09KB
NTI Completion of Placement
07/09/20 download Created with Sketch. 63.07KB
NTI Neurotech Proceeds to in vitro trials after Positive Results
07/09/20PRICE SENSITIVE download Created with Sketch. 472.55KB
NTI Neurotech secures Brain Therapeutics as Greece distributor
03/09/20 download Created with Sketch. 84.52KB
NTI Appendix 2A
02/09/20 download Created with Sketch. 217.56KB
NTI Appendix 4E and Annual Report Updated
31/08/20 download Created with Sketch. 731.36KB
NTI Appendix 4G
31/08/20 download Created with Sketch. 387.97KB
NTI Appendix 4E and Annual Report
31/08/20PRICE SENSITIVE download Created with Sketch. 718.09KB
NTI Results of Meeting
31/08/20 download Created with Sketch. 90.89KB
NTI Disclosure Document
26/08/20PRICE SENSITIVE download Created with Sketch. 422.17KB
NTI Response to ASX price query
21/08/20PRICE SENSITIVE download Created with Sketch. 657.35KB
NTI Pause in Trading
21/08/20PRICE SENSITIVE download Created with Sketch. 113.83KB
NTI Promising Early Results from Cannabinoid Analysis
21/08/20PRICE SENSITIVE download Created with Sketch. 136.93KB
NTI Trading Halt
19/08/20PRICE SENSITIVE download Created with Sketch. 156.17KB
NTI Ceasing to be a substantial holder
04/08/20 download Created with Sketch. 415.7KB
NTI Quarterly Report and Appendix 4C
30/07/20PRICE SENSITIVE download Created with Sketch. 453.14KB
NTI Notice of General Meeting/Proxy Form
28/07/20 download Created with Sketch. 1.18MB
NTI Neurotech commences assays on Dolce cannabis strains
27/07/20 download Created with Sketch. 191.21KB
NTI Appendix 2A
22/07/20 download Created with Sketch. 214.78KB
NTI Disclosure Document
15/07/20PRICE SENSITIVE download Created with Sketch. 374.05KB
NTI Change in substantial holding
15/07/20 download Created with Sketch. 124.48KB
NTI Proposed issue of Securities - NTI
03/07/20 download Created with Sketch. 24.71KB
NTI Proposed issue of Securities - NTI
03/07/20 download Created with Sketch. 38.63KB
NTI NTI Secures Option to Cannabis Strains Targeting Autism
03/07/20PRICE SENSITIVE download Created with Sketch. 143.12KB
NTI Trading Halt
01/07/20PRICE SENSITIVE download Created with Sketch. 328.64KB
NTI Reinstatement to Official Quotation
01/05/20PRICE SENSITIVE download Created with Sketch. 71.3KB
NTI Response to ASX Price and Volume Query
01/05/20PRICE SENSITIVE download Created with Sketch. 241.53KB
NTI Quarterly Report and Appendix 4C
29/04/20PRICE SENSITIVE download Created with Sketch. 280.75KB
NTI Continued Suspension
28/04/20 download Created with Sketch. 111.41KB
NTI Continued Suspension
20/04/20 download Created with Sketch. 89.77KB
NTI Suspension from Official Quotation
14/04/20PRICE SENSITIVE download Created with Sketch. 183.29KB
NTI Becoming a substantial holder x4
09/04/20 download Created with Sketch. 5.7MB
NTI Mente receives CE Mark renewal for use with ASD Children
09/04/20PRICE SENSITIVE download Created with Sketch. 170.22KB
NTI Trading Halt
08/04/20PRICE SENSITIVE download Created with Sketch. 213.23KB
NTI Pause In Trade
08/04/20PRICE SENSITIVE download Created with Sketch. 115.74KB
NTI Appendix 3G
06/04/20 download Created with Sketch. 279.99KB
NTI Secondary Trading Notice & Appendix 2A
06/04/20 download Created with Sketch. 416.02KB
NTI Mente Continues to Build Awareness in Europe
26/03/20 download Created with Sketch. 128.67KB
NTI Appendix 3G
04/03/20 download Created with Sketch. 280.3KB
NTI Secondary Trading Notice & Appendix 2A
04/03/20 download Created with Sketch. 368.73KB
NTI Appendix 4D & Half Year Report
25/02/20PRICE SENSITIVE download Created with Sketch. 394.5KB
NTI New Mente Autism Therapy Referral Program
24/02/20 download Created with Sketch. 133.83KB
NTI Response to Appendix 4C Query
17/02/20PRICE SENSITIVE download Created with Sketch. 268.3KB
NTI Ceasing to be a substantial holder
04/02/20 download Created with Sketch. 516.11KB
NTI Quarterly Report and Appendix 4C
03/02/20PRICE SENSITIVE download Created with Sketch. 327.11KB
NTI Cancellation of Mente Device from Australian TGA Register
28/01/20PRICE SENSITIVE download Created with Sketch. 97.39KB
NTI Trading Halt
24/01/20PRICE SENSITIVE download Created with Sketch. 155.47KB
NTI Change of Share Registry
20/01/20 download Created with Sketch. 234.34KB
NTI Neurotech Expands Distribution to Taiwan
17/12/19 download Created with Sketch. 70.45KB
NTI Mente Partnership with Australian Neurofeedback Institute
05/12/19 download Created with Sketch. 165.8KB
NTI Change of Director's Interest Notice x 4
19/11/19 download Created with Sketch. 838.99KB
NTI Appendix 3B - AGM Securities Issues
19/11/19 download Created with Sketch. 472.44KB
NTI Amended Constitution
19/11/19 download Created with Sketch. 456.71KB
NTI Results of Meeting
19/11/19 download Created with Sketch. 525.91KB
NTI Quarterly Report and Appendix 4C
31/10/19PRICE SENSITIVE download Created with Sketch. 198.79KB
NTI Notice of Annual General Meeting/Proxy Form
16/10/19 download Created with Sketch. 758.25KB
NTI Capital Raising
08/10/19 download Created with Sketch. 77.05KB
NTI Appendix 4G
30/08/19 download Created with Sketch. 234.82KB
NTI Appendix 4E and Annual Report to Shareholders
30/08/19PRICE SENSITIVE download Created with Sketch. 715.77KB
NTI Quarterly Update & Appendix 4C
31/07/19PRICE SENSITIVE download Created with Sketch. 279.41KB
NTI Response to ASX Price and Volume Query
18/07/19PRICE SENSITIVE download Created with Sketch. 252.46KB
NTI Response to ASX Price and Volume Query
05/06/19PRICE SENSITIVE download Created with Sketch. 669.72KB
NTI Neurotech launches Mente Clinic
05/06/19 download Created with Sketch. 85.8KB
NTI Change in substantial holding
03/06/19 download Created with Sketch. 75.94KB
NTI Change in substantial holding
03/06/19 download Created with Sketch. 63.88KB
NTI Response to ASX Price and Volume Query
29/05/19PRICE SENSITIVE download Created with Sketch. 192.56KB
NTI Pause In Trading
29/05/19PRICE SENSITIVE download Created with Sketch. 116.2KB
NTI Quarterly Activities and Cashflow Report
30/04/19PRICE SENSITIVE download Created with Sketch. 323.18KB
NTI Response to ASX Price Query
24/04/19PRICE SENSITIVE download Created with Sketch. 414.61KB
NTI Details of Company Address
23/04/19 download Created with Sketch. 55.87KB
NTI Initial Director's Interest Notice
18/04/19 download Created with Sketch. 150.95KB
NTI Initial Director's Interest Notice
18/04/19 download Created with Sketch. 150.42KB
NTI Appendix 3Z - P O'Connor
17/04/19 download Created with Sketch. 177.1KB
NTI Appendix 3Z - N Fong
17/04/19 download Created with Sketch. 176.71KB
NTI Appendix 3Z - S Trevisan
17/04/19 download Created with Sketch. 179.3KB
NTI New Board Appointments
16/04/19 download Created with Sketch. 174.6KB
NTI Ceasing to be a substantial holder
08/04/19 download Created with Sketch. 148.91KB
NTI Dr Adrian Attard Trevisan, clarification
28/03/19 download Created with Sketch. 117.51KB
NTI Dr Adrian Attard Trevisan
27/03/19PRICE SENSITIVE download Created with Sketch. 122.01KB
NTI New Subscription Model and E-Commerce platform for clinics
18/03/19 download Created with Sketch. 155.73KB
NTI Maltese Former Employee Claim
07/03/19 download Created with Sketch. 152.36KB
NTI Appendix 3Y - P O'Connor
01/03/19 download Created with Sketch. 212.8KB
NTI Appendix 3Y - P Griffiths
01/03/19 download Created with Sketch. 232.28KB
NTI Appendix 3Y - S Trevisan
01/03/19 download Created with Sketch. 214.1KB
NTI Appendix 4D and 31 December 2018 Half Year Report
28/02/19PRICE SENSITIVE download Created with Sketch. 1.01MB
NTI Becoming a substantial holder
28/02/19 download Created with Sketch. 621.41KB
NTI Change in substantial holding
27/02/19 download Created with Sketch. 188.88KB
NTI Appendix 3B
25/02/19 download Created with Sketch. 469.88KB
NTI RENOUNCEABLE PRO-RATA RIGHTS ISSUE
25/02/19PRICE SENSITIVE download Created with Sketch. 126.97KB
NTI Neurotech secures digital marketing partner
15/02/19 download Created with Sketch. 158.54KB
NTI Supplementary Prospectus
07/02/19PRICE SENSITIVE download Created with Sketch. 126.71KB
NTI Despatch of Prospectus
06/02/19 download Created with Sketch. 171.94KB
NTI Despatch of Notices to Shareholders
31/01/19 download Created with Sketch. 385.33KB
NTI Quarterly Report and Appendix 4C
31/01/19PRICE SENSITIVE download Created with Sketch. 498.23KB
NTI Despatch of Notice to Optionholders
30/01/19 download Created with Sketch. 323.77KB
NTI Appendix 3B
30/01/19 download Created with Sketch. 521.71KB
NTI CEO and Managing Director remuneration
29/01/19 download Created with Sketch. 161.77KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.4¢
Change
0.001(7.69%)
Mkt cap ! $14.69M
Open High Low Value Volume
1.3¢ 1.4¢ 1.3¢ $4.026K 307.2K

Buyers (Bids)

No. Vol. Price($)
1 1917576 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 505017 5
View Market Depth
Last trade - 16.10pm 29/08/2025 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.